Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Eur J Radiol. 2018 Nov 28;110:163–168. doi: 10.1016/j.ejrad.2018.11.031

Table 1.

Patient Characteristics. For Background parenchymal enhancement (BPE) and fibroglandular tissue (FGT), results are reported for each of two readers (R1 and R2).

Patient Group Total Number
Patients 27
Age (range) 53 (33-80)
Menopausal status
Post 14 (51.9%)
Pre 13 (48.1%)
Background Parenchymal Enhancement on MRI
Minimal 6 (22.2%) R1, 8 (29.6%) R2
Mild 14 (51.9%) R1, 12 (44.4%) R2
Moderate 6 (22.2%) R1,6 (22.2%) R2
Marked 1 (3.7%) R1, 1 (3.7%) R2
Fibroglandular Tissue on MRI
Almost Entirely Fatty 6 (22.2%) R1, 5 (18.5%) R2
Scattered Fibroglandular Tissue 8 (29.6%) R1, 8(29.6%) R2
Heterogeneous Fibroglandular Tissue 7 (25.9%) R1, 8(29.6%) R2
Extreme Fibroglandular Tissue 6 (22.2%) R1,6 (22.2%) R2
Breast Cancer Size
2 - 4 cm 24 (88.9%)
> 4 cm 3 (11.1%)
Histopathology
Invasive Ductal Cancer 24 (88.9%)
Invasive Lobular Cancer 1 (3.7%)
Invasive Mammary Cancer 2 (7.4%)